Fosun Pharma Buys Back 1.3 Million Shares for HKD 22.07 Million on September 15

Fosun Pharma (02196. HK) repurchased 1.30 million shares on September 15, 2026, at prices ranging from HKD 16.890 to HKD 17.100 per share, spending HKD 22.07 million. The stock closed at HKD 16.930 that day, down 1.11%, with turnover of HKD 57.16 million.

From September 9 to September 15, 2026, Fosun Pharma bought back shares on five consecutive trading days, repurchasing a total of 5.5375 million shares for HKD 92.68 million. The stock fell 1.91% over the period. So far in 2026, the company has carried out nine buybacks, repurchasing a total of 6.159 million shares for HKD 103 million.

On September 14, 2026, Fosun Pharma repurchased 1.455 million shares at prices ranging from HKD 16.300 to HKD 17.140 per share, for HKD 24.71 million. On September 11, it repurchased 1.34 million shares at prices ranging from HKD 16.140 to HKD 16.500 per share, for HKD 21.86 million. On September 10, it repurchased 1.29 million shares at prices ranging from HKD 16.400 to HKD 16.870 per share, for HKD 21.41 million. On September 9, it repurchased 152,500 shares at prices ranging from HKD 17.160 to HKD 17.260 per share, for HKD 2.63 million.

On September 7, 2026, Fosun Pharma repurchased 70,000 shares at prices ranging from HKD 16.740 to HKD 16.830 per share, for HKD 1.18 million. On September 1, it repurchased 264,000 shares at prices ranging from HKD 16.070 to HKD 16.280 per share, for HKD 4.28 million. On August 31, it repurchased 70,500 shares at prices ranging from HKD 16.010 to HKD 16.050 per share, for HKD 1.13 million. On August 27, it repurchased 217,000 shares at prices ranging from HKD 16.450 to HKD 16.590 per share, for HKD 3.59 million.